MIF antagonist antibodies Program (Carolus Therapeutics)

N/A

Report date: 2024/12/06 09:47:04

Base Information

Drug NameMIF antagonist antibodies Program (Carolus Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarolus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarolus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A